PYRAZOLPYRAMIDINON DERIVATIVE-CONTAINING MEDICINE FOR LIVER DISEASES TREATMENT AND PREVENTION Russian patent published in 2009 - IPC A61K31/522 A61P1/16 

Abstract RU 2369392 C2

FIELD: medicine.

SUBSTANCE: invention relates to hepatic fibrosis inhibitor containing pyrazolopyrimidinon derivative of the following formula (1) as active ingredient, pharmaceutical composition for liver cirrhosis treatment and prevention, portal hypertension inhibitor comprising pyrazolopyrimidinon formula derivative (1), pharmaceutical composition as prevention care for treatment of complications caused by portal hypertension and containing pyrazolopyrimidinon formula (1) derivative as active ingredient.

EFFECT: improved medical compliance in patients suffering from liver diseases.

5 cl

Similar patents RU2369392C2

Title Year Author Number
USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE 2018
  • Nesteruk Vladimir Viktorovich
  • Syrov Kirill Konstantinovich
RU2692243C1
ANTAGONISTS OF ALPHAVBETA3 AND ALPHAVBETA6 INTEGRINS AND ANTIFIBROTIC AGENTS 2004
  • Gudman Zimon
  • Shuppan Detlef
  • Patzenker Ehleonora
  • Popov Jurij
  • Bauer Mikhaehl'
  • Vizner Mattias
  • Jonchik Al'Fred
RU2388472C2
MEDICATION FOR TREATMENT AND PREVENTION OF PROSTATIC HYPERPLASIA, CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE 2006
  • Ju Dzae Jang
  • Choi Seul Min
  • Kang Kiung Koo
  • Akhn Bioung Ok
  • Joo Mookhi
RU2418590C2
METHOD FOR THE TREATMENT OF PATIENTS WITH LIVER CIRRHOSIS COMPLICATED BY PORTAL HYPERTENSION AND HYPERSPLENISM 2021
  • Shabunin Aleksej Vasilevich
  • Bedin Vladimir Vladimirovich
  • Drozdov Pavel Alekseevich
  • Tsurkan Vladimir Andreevich
  • Zhuravel Olesya Sergeevna
RU2783657C1
THERAPEUTIC COMPOSITIONS CONTAINING SPECIFIC ENDOTHELIN RECEPTOR ANTAGONIST AND PDE5 INHIBITOR 2007
  • Klozel' Martine
RU2462249C2
METHOD FOR PREDICTING CIRRHOTIC STAGE OF CHRONIC VIRAL HEPATITIS 2005
  • Shabrov Aleksandr Vladimirovich
  • Shapiro Izjaslav Jakovlevich
  • Karev Vadim Evgen'Evich
  • Sologub Tamara Vasil'Evna
  • Gorelov Aleksandr Igorevich
RU2321353C2
APPLYING OLTIPRAZ FOR PROPHYLAXIS AND TREATMENT OF LIVER FIBROSIS AND CIRRHOSIS AND OLTIPRAZ-CONTAINING PHARMACEUTICAL COMPOSITION 2001
  • Kim Sang Geon
  • Kang Keon Vuk
RU2258509C2
METHOD FOR PREDICTING RISK OF BLEEDING FROM VARICOSE VEINS OF STOMACH AND ESOPHAGUS AFTER SURGICAL INTERVENTION IN THE SCOPE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNTING WITH SELECTIVE EMBOLIZATION OF GASTRIC VEINS 2022
  • Kalinin Denis Sergeevich
  • Sapronova Nataliya Germanovna
  • Khoronko Yurij Vladilenovich
  • Stagniev Dmitrij Vyacheslavovich
  • Kosovtsev Evgenij Valerevich
  • Putilina Anna Maksimovna
RU2804674C1
METHOD FOR TREATING COMPLICATIONS CAUSED BY A TOTAL DISCHARGE OF BLOOD FROM THE PORTAL SYSTEM INTO THE INFERIOR VENA CAVA IN CHILDREN UNDERGOING SIDE-TO-SIDE SPLENORENAL SHUNTING OR SPLENOSUPRENAL SHUNTING FOR PORTAL HYPERTENSION 2022
  • Razumovskij Aleksandr Yurevich
  • Margaryan Sergej Rubenovich
RU2789284C1
METHOD FOR DETERMINING THE RISK OF HYPERCOAGULABILITY IN PATIENTS WITH PORTAL HYPERTENSION OF CYRRHOTIC GENESIS AFTER PORTOSYSTEMIC SHUNT PLACEMENT 2017
  • Svetova Eleonora Vladimirovna
  • Sapronova Nataliya Germanovna
  • Shlyk Irina Fedorovna
RU2665118C1

RU 2 369 392 C2

Authors

Choi Seul Min

Akhn Bioung Ok

Joo Mookhi

Dates

2009-10-10Published

2005-10-21Filed